((自动化翻译由路透提供，请见免责声明 ))
9月30日 - ** Biohaven公司 股价在延时交易中下跌1%，至49.49美元，该公司寻求融资
** 生物制药公司开始 (link) 2.5亿美元的一般用途股票发行
** BHVN 周一收盘下跌 2%，报 49.97 美元。
* (link) * 上周一，该公司的药物 troriluzole 达到了一项针对脊髓小脑共济失调$(SCA)$ 的研究的主要目标，这种遗传性神经退行性疾病主要影响小脑，之后该公司股价上涨了约 14%，报收于 45.94 美元。
** 公司拥有约 9 450 万股已发行股票，市值约为 47 亿美元（根据伦敦证交所集团数据）。
** 年初至今，股价上涨约 17%，在过去 12 个月中几乎翻了一番
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.